GlassScriptPhysician profile
Louis B Glade
NPI 1265498869
$3,565.65
in general payments reported to CMS, 2019-2025
22 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $1,328 · 2021: $68.33 · 2022: $214 · 2023: $442 · 2024: $571 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,440.47 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,017.26 | 2019-2025 | |
| Medtronic, INC. | $259.73 | 2021-2025 | Micra, Linq II |
| Shockwave Medical, INC | $105.60 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $79.37 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $74.07 | 2021-2024 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $72.53 | 2022-2025 | Assure Wcd |
| Pfizer INC. | $67.57 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.34 | 2022-2025 | Jardiance |
| Cvrx, INC. | $49.05 | 2023 | Barostim Neo System |
| Angiodynamics, INC. | $47.09 | 2023 | Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.14 | 2019-2024 | Lifevest |
| Philips North America LLC | $36.98 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Baxter Healthcare | $34.46 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $31.38 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $28.13 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lantheus Medical Imaging, INC. | $27.18 | 2024 | |
| Abbott Laboratories | $21.10 | 2019 | |
| Novo Nordisk INC | $21.03 | 2023 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $16.56 | 2019 | |
| Vifor Pharma, INC. | $13.97 | 2019 | |
| Irhythm Technologies, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Glade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.